Limited evidence, faulty reasoning, and potential for a global opioid crisis

Other countries must learn from the public health devastation in the US

[1]  M. Stanbrook,et al.  A 1980 Letter on the Risk of Opioid Addiction. , 2017, The New England journal of medicine.

[2]  D. Fiellin,et al.  Abuse-Deterrent Opioid Formulations - Putting the Potential Benefits into Perspective. , 2017, The New England journal of medicine.

[3]  Agnieszka Sorokowska,et al.  Predatory journals recruit fake editor , 2017, Nature.

[4]  D. Baker.  History of The Joint Commission's Pain Standards: Lessons for Today's Prescription Opioid Epidemic. , 2017, JAMA.

[5]  Sri Suryawati,et al.  Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study , 2016, The Lancet.

[6]  R. Chambers,et al.  Pseudoaddiction: Fact or Fiction? An Investigation of the Medical Literature , 2015, Current Addiction Reports.

[7]  R. Chou,et al.  The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop , 2015, Annals of Internal Medicine.

[8]  D. Fiellin,et al.  Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons. , 2014, The International journal on drug policy.

[9]  B. Larance,et al.  The availability, diversion and injection of pharmaceutical opioids in South Asia. , 2011, Drug and alcohol review.

[10]  J. Haddox,et al.  Opioid pseudoaddiction — an iatrogenic syndrome , 1989, Pain.

[11]  Art Van Zee,et al.  The Promotion and Marketing of OxyContin : Commercial Triumph , Public Health Tragedy , 2009 .